Markets

AXT Shares Retreat on Insider Sale Plans Following Sector Rally

AXT Inc shares declined over 6% in premarket trading Tuesday, giving back part of Monday's 22% surge. SEC filings revealed the CEO, CFO, and a director filed to sell a combined 753,801 shares worth approximately $30.2 million.

Daniel Marsh · · · 3 min read · 2 views
AXT Shares Retreat on Insider Sale Plans Following Sector Rally
Mentioned in this article
AXTI $44.68 +17.89% COHR $275.12 -7.96% LITE $783.25 +11.75% NVDA $179.27 -1.76%

Shares of AXT Inc (AXTI) retreated in Tuesday's premarket session, declining 6.5% to $43.33. This pullback followed a substantial rally the previous day, during which the stock surged 22.2% to close at $46.32. The sharp reversal comes as regulatory filings disclosed plans by several company insiders to sell a significant block of shares.

Insider Sale Filings Emerge

Securities and Exchange Commission Form 144 filings revealed that CEO Morris Young, Chief Financial Officer Gary Fischer, and director Jesse Chen have filed notices to sell a combined 753,801 shares. Based on current market prices, these shares are valued at approximately $30.2 million. Specifically, CEO Morris S. Young filed to sell 159,536 shares, CFO Gary L. Fischer filed for 494,265 shares, and director Jesse Chen filed for 100,000 shares.

It is important to note that a Form 144 filing serves as a notice of intent to sell restricted or "control" securities under SEC Rule 144. It indicates a plan to sell but does not confirm that a transaction has been executed. The filings are procedural paperwork that precedes any actual sale.

Context of the Recent Rally

The stock's volatility occurs against a backdrop of heightened investor interest in photonics and data-center optics companies. This sector enthusiasm was ignited by Nvidia's announcement of plans to invest $2 billion each in Lumentum Holdings Inc. and Coherent Corp., aiming to bolster its artificial intelligence processor supply chain. Following that news, Lumentum shares rose 5%, while Coherent jumped 9% in early trading Monday.

AXT's trading on Monday was exceptionally active. The stock opened at $41.72, swung between a low of $39.30 and a high of $47.03, and finally settled at $46.32. Trading volume reached 12.85 million shares, significantly above average levels.

Financial and Operational Background

The Fremont, California-based company anticipates sequential revenue growth for the first quarter, driven by strong demand for its indium phosphide substrates from AI infrastructure customers. This outlook comes despite the company falling short of its own export permit expectations in the fourth quarter. CEO Morris Young stated, "We are also on track to double our indium phosphide manufacturing capacity this year."

For the fourth quarter, AXT reported revenue of $23.0 million. The company posted a GAAP net loss of $3.5 million, or 8 cents per share. On a non-GAAP basis, excluding stock-based compensation, the net loss was $2.3 million, or 5 cents per share.

A separate SEC Form 4 filing showed that CFO Gary Fischer recently acquired 247,828 common shares on February 26 through the exercise of stock options, paying between $3.06 and $9.50 per share. Following these transactions, his total stake increased to 685,543 shares.

Market Watch and Forward Look

Traders are closely monitoring whether the stock can maintain levels above Monday's close during Tuesday's regular session. The market is also attentive to whether the filed insider sales materialize in upcoming transaction reports. Broader concerns include the status of the company's export permits, which remain pending.

The company's next earnings report is scheduled for April 23, which will provide further insight into its financial performance and the progress of its capacity expansion plans. The interplay between strong fundamental demand from the AI sector and the technical pressure from potential insider selling is likely to dictate near-term price action for AXT shares.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →